Factors associated with antihypertensive drug compliance in 83 884 Chinese patients: a cohort study

被引:32
作者
Wong, M. C. S. [1 ]
Jiang, J. Y. [1 ]
Griffiths, S. M. [1 ]
机构
[1] Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China
关键词
DIAGNOSED HYPERTENSIVE PATIENTS; BLOOD-PRESSURE CONTROL; MEDICATION COMPLIANCE; HONG-KONG; PERSISTENCE; THERAPY; ADHERENCE; DISCONTINUATION; NONCOMPLIANCE; PATTERNS;
D O I
10.1136/jech.2009.091603
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Few studies address the profiles of antihypertensive compliance among ethnic Chinese. The levels of and factors associated with antihypertensive drug compliance among Chinese patients were evaluated in this study. Methods All Chinese hypertensive patients who paid at least two consecutive visits in any government primary care clinics for antihypertensive drug refill in a large territory of Hong Kong from January 2004 to June 2007 were included. Medication possession ratio (MPR), defined as the ratio of total days of medication supplied (not including the last prescription) to total days in a period of time, was used a measure of drug compliance. Results From 83 884 eligible patients, 71 685 (85.5%) had good compliance to antihypertensive drugs (MPR >= 80%). Binary logistic regression analysis was conducted, with good compliance as the outcome variable while controlling for potential confounders. Advanced age (adjusted ORs (aOR) 1.36-1.55, p < 0.001), female gender (aOR for male patients 0.84, 95% CI 0.80 to 0.87, p < 0.001), payment of fees (aOR 1.14, 95% CI 1.09 to 1.19, p < 0.001), attendance in family medicine specialist clinic (aOR 1.52, 95% CI 1.40 to 1.66, p < 0.001), follow-up visits (aOR 3.21, 95% CI 3.06 to 3.36, p < 0.001) and use of drugs acting on the renin-angiotensin system (aOR 1.18, 95% CI 1.07 to 1.30, p = 0.001) were positively associated with good compliance to drugs. Use of beta-blockers was negatively associated with drug compliance (aOR 0.78, 95% CI 0.73 to 0.84, p < 0.001). Conclusions Physicians should practice caution when prescribing antihypertensive drugs to patients with these factors where closer monitoring of their compliance patterns is warranted.
引用
收藏
页码:895 / 901
页数:7
相关论文
共 46 条
  • [11] Queen Mary Utilization of Antihypertensive Drugs Study: Side-effects of antihypertensive drugs
    Cheung, BMY
    Wong, YL
    Lau, CP
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (04) : 391 - 399
  • [12] Benefits of adherence to anti-hypertensive drug therapy
    Flack, JM
    Novikov, SV
    Ferrario, CM
    [J]. EUROPEAN HEART JOURNAL, 1996, 17 : 16 - 20
  • [13] Compliance and persistence with newer antihypertensive agents
    Gerth, WC
    [J]. CURRENT HYPERTENSION REPORTS, 2002, 4 (06) : 424 - 433
  • [14] Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data
    Halpern, Michael T.
    Khan, Zeba M.
    Schmier, Jordana K.
    Burnier, Michel
    Caro, J. Jaime
    Cramer, Joyce
    Daley, William L.
    Gurwitz, Jerry
    Hollenberg, Norman K.
    [J]. HYPERTENSION, 2006, 47 (06) : 1039 - 1048
  • [15] *HDFP COOP GROUP, 1979, JAMA-J AM MED ASSOC, V242, P2562
  • [16] Persistence and adherence with antihypertensive drug therapy in a German sickness fund population
    Hoeer, A.
    Gothe, H.
    Khan, Z. M.
    Schiffhorst, G.
    Vincze, G.
    Haeussler, H. A.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (09) : 744 - 746
  • [17] *HOSP AUTH, HA CLIN RES SUPP OUT
  • [18] Factors related to non-compliance with antihypertensive drug therapy
    Jokisalo, E
    Kumpusalo, E
    Enlund, H
    Halonen, P
    Takala, J
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (08) : 577 - 583
  • [19] Kaplan NM FJ., 2006, Kaplan's clinical hypertension, V9th
  • [20] Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3